Hematology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hematology

Filter
19 Mar 2021

Advanced CAR T-Cell Therapy for Multiple Myeloma

PROMISING results of a newly advanced chimeric antigen receptor (CAR) T-cell therapy showed that more than triple the period remission for multiple myeloma.
15 Dec 2020

Could This New Model Predict Cytokine Release Syndrome in Immunotherapy Patients?

While many new immunotherapies are increasing cancer survival rates, tools to predict how the immunotherapy will impact a patient’s immune system are not…
15 Dec 2020

Patients with Sickle Cell Disease Identified as a Vulnerable COVID-19 Population

Hospitalisation of patients with sickle cell disease (SCD) who have coronavirus disease (COVID-19) is reported to be notably higher than the average…
11 Sep 2020

T Cell Function Modulated by Lymph Node Acidity

ACTIVATION of T cells within lymph nodes is an important component of effective immunity, but recent research has shown that this activation may be…
11 Sep 2020

What is the Mechanism for Blood Clotting in COVID-19?

THROMBOSIS is a significant contributor to morbidity and mortality in coronavirus disease-2019 (COVID-19), and researchers may have identified the…
15 Jun 2020

Convalescent Plasma Transfusion Therapy for COVID-19 Shows Promise

CONVALESCENT plasma transfusion for the treatment of severe COVID-19 is currently being trialled in the UK
15 Jun 2020

Will Selective CAR T Cells for Acute Myeloid Leukaemia Replace Chemotherapy?

IMMUNOTHERAPY for acute myeloid leukaemia (AML) has shown promise in recent years, and now results from a study that demonstrated improved selectivity
New Drug Approved for Multiple Myeloma Treatment
17 Mar 2020

New Drug Approved for Multiple Myeloma Treatment

ISATUXIMAB (Sarclisa®, Sanofi), an anti-CD38 monoclonal antibody, has received approval by the U.S. Food and Drug Administration…
We’ve noticed you’re accessing
from North/South America.